Skip to main content

Colony Group LLC

SEC CIK
0001080628
Latest filing
Nov 14, 2023

NVCR holding history

NovoCure Ltd in every 13F filed by Colony Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVCR overviewAll 13F holders of NVCRFull Q3 2023 holdings

Shares (Q3 2023)
89,926
Value
$1.45M
% of portfolio
<0.1%
Quarters held
11
Since Q1 2021
Holdings of NVCR by Colony Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 202389,926$1.45M<0.1%−2,827−3.0%ReducedHolders
Q2 202392,753$3.85M0.1%+88,821+2,258.9%AddedHolders
Q1 20233,932$236.0K<0.1%−99,831−96.2%ReducedHolders
Q4 2022103,763$7.61M0.1%+11,970+13.0%AddedHolders
Q3 202291,793$6.97M0.1%−303−0.3%ReducedHolders
Q2 202292,096$6.40M0.1%+4,347+5.0%AddedHolders
Q1 202287,749$7.27M0.1%+5,181+6.3%AddedHolders
Q4 202182,568$6.20M0.1%+786+1.0%AddedHolders
Q3 202181,782$9.50M0.2%−6,651−7.5%ReducedHolders
Q2 202188,433$19.6M0.4%−5,773−6.1%ReducedHolders
Q1 202194,206$12.5M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.